Sichuan Guowei Pharmaceutical Co., Ltd.'s first imitation of "dutasteride soft capsule" was approved
-
Last Update: 2020-01-20
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In vernacular On January 16, Sichuan Guowei Pharmaceutical Co., Ltd declared dutasteride soft capsules according to the new 4 categories, which was approved by the State Food and Drug Administration for listing, was deemed to have passed the consistency evaluation Dutasteride is a 5 α - reductase inhibitor developed by GSK It was first approved by FDA on November 20, 2001, and was approved on March 23, 2011 in China for the treatment of moderate and severe symptoms of benign prostatic hyperplasia (BPH) Its trade name is anfuda In 2018, anfuda's global sales were £ 572 million.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
